摘要：A series of new technologies and adjuvant therapies have been advocated in order to improve the success of IVFtreatment. Dehydro-epiandrostenedione, growth hormones, Coenzyme Q 10, calcium ionosphores, immunetherapy, heparin, low-dose aspirin, and vasodilators are among commonly prescribed pharmacological adjuvants.New technologies that are proposed to improve IVF outcomes include advanced sperm selection procedures, timelapseembryo monitoring, preimplantation genetic screening, assisted hatching endometrial injury or embryo-glue.This review looked into current evidence to justify the use of these co-interventions and whether some of them canstill be offered while awaiting more robust evidence to confirm or refute their role.
